Welcome to our dedicated page for BED BATH & BEYOND SEC filings (Ticker: BYON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BED BATH & BEYOND's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BED BATH & BEYOND's regulatory disclosures and financial reporting.
Beyond, Inc. reported that, effective August 18, 2025, it changed its corporate name to Bed Bath & Beyond, Inc. through a certificate of amendment to its certificate of incorporation. The Board of Directors approved this change under Delaware law without a stockholder vote, and the amendment only updates the corporate name without altering stockholder rights.
The company’s common stock is expected to continue trading on the NYSE under the ticker BYON until the close of market on August 28, 2025. Trading is then expected to begin under the new ticker BBBY when markets open on August 29, 2025. On August 20, 2025, the Board also adopted Fifth Amended and Restated Bylaws, effective immediately, with detailed changes set out in exhibits to the report.
Form 144 filed for Beyond, Inc. (BYON) discloses the intended sale of 2,200 common shares through broker Raymond James. At the quoted market price, the proposed transaction is valued at $22,000. The filer plans to execute the trade on or after 07/21/2025 on the NYSE.
The shares derive from restricted stock units (RSUs) that vested on 04/01/2021. Total shares outstanding are listed at 57.68 million, so the planned sale equals roughly 0.004 % of the company’s float—an amount that is immaterial to overall supply-demand dynamics. No sales were reported in the prior three-month period, and no additional consideration beyond the RSU vesting is indicated.
Because the notice covers a routine, small-scale insider sale and lacks any disclosure of undisclosed material information, the filing is generally viewed as administrative rather than market-moving.